C-aryl glycoside compounds for the treatment of diabetes and obesity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8486897
APP PUB NO 20110034402A1
SERIAL NO

12935468

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of formula (I) and pharmaceutically acceptable salts thereof, for use in the prevention and treatment of diseases including diabetes.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TFCHEM27100 VAL DE REUIL

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Castelot-Deliencourt-Godefroy, Géraldine Rouen, FR 3 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 16, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00